---
figid: PMC11767231__medicina-61-00062-g001
figtitle: CBM complex controls T cell signaling by the mammalian target of rapamycin
  (mTOR), nuclear factor kappa B (NFKB), and c-Jun N-terminal kinase activation (JNK)
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11767231
filename: medicina-61-00062-g001.jpg
figlink: /pmc/articles/PMC11767231/figure/F1/
number: F1
caption: The CBM complex controls T cell signaling by the mammalian target of rapamycin
  (mTOR), nuclear factor kappa B (NF-κB), and c-Jun N-terminal kinase activation (JNK).
  The T cell receptor leads to the transportation of glutamine, initiating the mTOR
  pathway
papertitle: Inborn Errors of Immunity Presenting with Early-Onset Severe Atopy
reftext: Nipat Chuleerarux, et al. Medicina (Kaunas). 2025 Jan;61(1).
year: '2025'
doi: 10.3390/medicina61010062
journal_title: Medicina
journal_nlm_ta: Medicina (Kaunas)
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: inborn errors of immunity | primary immune deficiencies | atopy | atopic
  dermatitis
automl_pathway: 0.9561008
figid_alias: PMC11767231__F1
figtype: Figure
redirect_from: /figures/PMC11767231__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11767231__medicina-61-00062-g001.html
  '@type': Dataset
  description: The CBM complex controls T cell signaling by the mammalian target of
    rapamycin (mTOR), nuclear factor kappa B (NF-κB), and c-Jun N-terminal kinase
    activation (JNK). The T cell receptor leads to the transportation of glutamine,
    initiating the mTOR pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - CARD11
  - CARD14
  - MTOR
  - MALT1
  - CARMIL2
  - NFKB1
  - SLC1A5
  - card11
  - card14
  - mtor
  - malt1
  - malt2
  - carmil2
  - Glutamine
---
